MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 May 2023 Evaluate
The Revenue for the quarter ended  March 2023 of Rs. 2099.01 millions grew by 16.46 % from Rs. 1802.34 millions.Net Profit witnessed a 47332.37% growth almost the double from Rs. 1.39 millions to Rs. 659.31  millions  of same quarter last year.The company reported a good operating profit of 414.17 millions compared to 312.25 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2099.01 1802.34 16.46 6658.98 5569.74 19.56 6658.98 5569.74 19.56
Other Income 17.29 17.47 -1.03 194.31 90.03 115.83 194.31 90.03 115.83
PBIDT 414.17 312.25 32.64 1030.49 662.62 55.52 1030.49 662.62 55.52
Interest 74.84 44.59 67.84 322.26 320.12 0.67 322.26 320.12 0.67
PBDT 731.43 267.66 173.27 1100.33 342.50 221.26 1100.33 342.50 221.26
Depreciation 72.12 266.27 -72.91 547.86 870.21 -37.04 547.86 870.21 -37.04
PBT 659.31 1.39 47332.37 552.47 -527.71 -204.69 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 659.31 1.39 47332.37 552.47 -527.71 -204.69 552.47 -527.71 -204.69
Equity 408.16 408.16 0.00 408.16 408.16 0.00 408.16 408.16 0.00
PBIDTM(%) 19.73 17.32 13.89 15.48 11.90 30.08 15.48 11.90 30.08
Peers
Company Name CMP
Sun Pharma. Inds. 1847.55
Dr. Reddys Labs. 1142.10
Cipla 1355.20
Lupin 2043.20
Zydus Lifesciences 1097.20
View more..